ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisSwingTradeArbitrageSearch

$IONS:NASDAQ · Ionis Pharmaceuticals Inc - US

Sector: health

Conviction from: NASDAQ

52-week range: 27.2586.74

A biopharmaceutical company that pioneers antisense and RNA-targeting drug technology to develop treatments for cardiovascular, neurological and rare diseases.

4 tracked filer(s) hold this · 1 opened, 2 added, 1 trimmed in 30-SEP-2026

Aggregate 13FScore 60 — mean of 4 scored holder(s) · buyers (new/add) avg 66. Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Paul Tudor Jones / Tudor61New buy13,000,000$14,282,4500.0%
Steve Cohen / Point7275Added +3571%1,255,588$56,062,0040.1%
Paul Tudor Jones / Tudor61Added +20%47,382$2,115,6060.0%
Ancora42Trimmed -10%2,000$89,3000.0%

Beyond 13F — activists, insiders, politicians & research

Insider open-market buys daily digest →

FiledInsiderRoleSharesValue
2026-07-31Hayden Michael Rdirector20,000$1,058,700Form 4

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.